Stockreport

TransCode Therapeutics Reports 2023 Results; Provides Business Update

TransCode Therapeutics, Inc.  (RNAZ) 
PDF BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RN [Read more]